Coming up Tuesday October 18th, I will interview a research fellow at Ichor, Jennifer DeRosa who is working to further the LysoSENS branch of the SENS platform. She will be working to reliably scale up a therapeutic substance that degrades A2E in order to prepare for in vivo testing, with the end goal being to cure macular degenration.
Please submit any questions you have in the next 24 hours and I will be sure to ask them during the podcast/interview.
Jennifer tells me she has had success scaling up the AMD therapeutic and things are moving along quickly. I was a little disappointed when she mentioned that no one she knew from her former university had heard about SENS or was interested in rejuvenation technology.
A short interview that should give you a good idea of how your generous support is going to LongeCity Affiliate Labs and moving rejuvenation research forward.
You Are Using Ad Block Plus or some other advert blocking software. More info here: "https://www.longecity.org/forum/topic/84454-please-disable-adblockers/